Calgary, Alberta--(Newsfile Corp. - January 21, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is...
BENNINGTON, NE / ACCESSWIRE / January 21, 2022 / Moxie founders, Adam Gomez and Shari Dalton, launch CliniSight LLC to...
Live video webcast presentation on Wednesday, January 26th at 1:00 PM ETRENO, NV / ACCESSWIRE / January 21, 2022 /...
HAMILTON, BERMUDA / ACCESSWIRE / January 21, 2022 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to addressing unmet medical...
Vice Chairman, John E. Niederhuber, M.D., to Assume Chairmanship, Effective April 1, 2022SEATTLE, WA / ACCESSWIRE / January 21, 2022...
Toronto, Jan. 21, 2022 (GLOBE NEWSWIRE) -- An estimated 1.5 billion people across the globe experience some level of difficulty...
Tampa, Jan. 21, 2022 (GLOBE NEWSWIRE) -- There is now a place for men to discover discreet, trustworthy, vetted advice...
DENVER, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM; TSXV: IOM), a provider...
BRISBANE, Calif. and ST. LOUIS, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Arch Oncology, Inc., a clinical-stage immuno-oncology company focused on...
Oak Ridge, TN, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement...
Further enhances the Board’s scientific and commercialization experience supporting key market launchesBUFFALO, N.Y, Jan. 21, 2022 (GLOBE NEWSWIRE) -- 22nd...
Administration of one-time hematopoietic stem cell (HSC) gene therapy resulted in sustained, clinically meaningful benefits by preserving cognitive function and...
COVISHIELD (STI-9167) neutralizing antibody (nAb) was discovered by scientists from the Icahn School of Medicine at Mount Sinai (“Icahn Mount...
TOKYO, Japan and CAMBRIDGE, United Kingdom, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Sosei Group Corporation (“the Company”; TSE: 4565) will...
Press ReleaseNicox Provides Fourth Quarter 2021 Business and Financial HighlightsMont Blanc Phase 3 clinical trial of NCX 470 in glaucoma...
Fitness Industry Giant And Recovery Leader Come Together To Provide Full Body Wellness To 24 Hour Fitness Members HOUSTON, TEXAS,...
CHENGDU, China, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global clinical-stage biotechnology company developing...
MARKHAM, Ontario, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it...
Phase 2 trial to evaluate reduction in heavy drinking as measured by a change in the World Health Organization drinking...
SANTA MONICA, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Correction: Opiant Pharmaceuticals, Inc. (“Opiant” or “Company”) (NASDAQ: OPNT), a specialty...